Searchable abstracts of presentations at key conferences in endocrinology

ea0081p644 | Endocrine-Related Cancer | ECE2022

Sublethal hyperthermia decreases cellular proliferation and transiently disrupts steroidogenesis in adrenal cells

Mullen Nathan , Donlon Padraig , Duffy Katen , Feely Sarah , Warde Kate M , Sorushanova Anna , Prakash Punit , O'Halloran Martin , Dennedy Michael Conall

Introduction: Primary Aldosteronism is the most common cause of secondary hypertension. First-line treatment; adrenalectomy resects adrenal nodules and adjacent normal tissue, limiting suitability to those who present with unilateral disease. Use of thermal ablation represents an emerging approach as a possible minimally invasive therapy for unilateral and bilateral disease, to target and disrupt hypersecreting aldosterone producing adenomas, while preserving adjacent normal a...

ea0081p263 | Adrenal and Cardiovascular Endocrinology | ECE2022

Development of a novel treatment strategy which involves thermal ablation of adrenal adenomas using electromagnetic energy

Farnan Richard , Bottiglieri Anna , Farina Laura , Senanayake Russell , Gurnell Mark , Prakash Punit , O'Halloran Martin , Cappiello Grazia , Newell Caoimhe , Keating Muireann , Rahmani George , Conall Dennedy Michael

Primary aldosteronism (PA) arises from one or both adrenal glands and is a common cause of secondary hypertension accounting for approximately 5-12% of all hypertension. Current therapy involves mineralocorticoid receptor antagonists for bilateral disease (60%) or adrenalectomy for unilateral disease (30%). We investigate treatment planning of percutaneous adrenal ablation as an alternative definitive therapeutic modality for unilateral and bilateral disease. The main objectiv...

ea0081ep74 | Adrenal and Cardiovascular Endocrinology | ECE2022

Magnetic iron oxide nanoparticles for the delivery of thermal therapy for the treatment of primary aldosteronism

Sorushanova Anna , Donlon Padraig , Covarrubias-Zambrano Obdulia , Covarrubias Jose , Varghese Sunitha , Owens Peter , O'Halloran Martin , Prakash Punit , Bossmann Stefan , Dennedy Michael Conall

To minimise damage to surrounding tissues, targeted delivery of therapeutics to the tumour is highly desirable, and the development of nanotechnology has shown promising results. Magnetic iron oxide nanoparticles (MIONPs) have been gaining traction over the years for applications such as drug delivery, molecular imaging and delivering hyperthermia for treatment of various cancers (1). MIONPs have great therapeutic potential as they can be produced in various sizes and shapes, ...

ea0090p552 | Adrenal and Cardiovascular Endocrinology | ECE2023

Non-specific uptake of magnetic iron oxide nanoparticles by Adrenocortical carcinoma and Endothelial cells

Sorushanova Anna , Donlon Padraig , Mullen Nathan , Covarrubias-Zambrano Obdulia , Covarrubias Jose , Varghese Sunitha , Hantel Constanza , Owens Peter , O'Halloran Martin , Prakash Punit , Bossman Stefan , Conall Dennedy Michael

Adrenocortical carcinoma is a rare malignant tumour that starts in the adrenal gland, accounting for 4% of all adrenal tumours. Functioning ACC can cause symptoms related to the overproduction of hormones and large tumours can press on nearby organs. Primary treatment for ACC tumour is surgery to remove the tumour, and may also include Chemotherapy or Radiation to stop the cancer cells from spreading. Therefore, more affective therapies for delivering therapeutics to the tumou...

ea0073aep77 | Adrenal and Cardiovascular Endocrinology | ECE2021

Hyperthermia differentially affects cortisol and aldosterone secretion under stimulated conditions

Donlon Padraig , Mullen Nathan , Warde Kate , Bottiglieri Anna , Cappiello Grazia , Farina Laura , Basel Matthew , Martin O’Halloran , Prakash Punit , Paula O’Shea , Dennedy Michael Conall

IntroductionPrimary Aldosteronism (PA) is the commonest secondary cause of hypertension. Mainstay therapy, adrenalectomy resects both hypersecreting and adjacent normal tissue. It is therefore only suitable for patients with unilateral disease (40% cases), whom are surgical candidates. Thermal therapy presents a plausible minimally invasive therapy, to target and disrupt hypersecreting aldosterone producing adenomas (APA), while also preserving adjacent ...

ea0063p441 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Microwave ablation of the adrenal gland for treatment of functioning adrenocortical tumours: porcine in vivo study

Donlon Padraig , Fallahi Hojjatollah , Beard Warren Beard , Shazad Atif , Heflin Lindsay , Cox Whitney , Bloomberg Brooke , Lillich James , Ganta Chanran , O'Sullivan Gerard , Ruvio Giuseppi , O'Shea Paula , O'Halloran Martin , Prakash Punit , Dennedy Michael

Objective: To evaluate MTA as a precision ablation methodology for adrenocortical tissue, simultaneously evaluating effects on adjacent non-targeted tissue.Methodology: A directional MTA applicator was used in vivo on adrenals of 8 male pigs: (i) sham (n=2); (ii) 45 watts for 60 seconds (n=3); (iii) 70 watts for 60 seconds (n=3). Blood was drawn intraprocedurally and at 48h for measurement of metanephrines, cortisol, A...

ea0032p156 | Calcium and Vitamin D metabolism | ECE2013

MSIA–SRM assay for parathyroid hormone and vitamin D binding protein: correlation with clinical immunoassay methods and application to clinical samples

Moniz Caje , Couchman Lewis , Krastins Bryan , Lopez Mary , Prakash Amol , Sarracino David , Vogelsang Mary , Peterman Scott , Vadali Gouri , Robinson Sarah

Parathyroid hormone is involved in calcium homeostasis through interactions with vitamin D. Because intact and truncated forms of PTH vary in their biological activity, assays that can accurately quantify the ratio of intact hormone to its fragments are of increasing significance in the diagnosis of endocrine, renal and bone diseases. Vitamin D and its metabolites circulate tightly bound to vitamin D-binding protein (DBP). Because DBP concentrations are altered in pregnancy, l...

ea0031p41 | Clinical biochemistry | SFEBES2013

MSIA-SRM assay for parathyroid hormone and vitamin D binding protein: correlation with clinical immunoassay methods and application to clinical samples

Couchman Lewis , Krastins Bryan , Lopez Mary , Prakash Amol , Sarracino David , Vogelsang Maryann , Peterman Scott , Vadali Gouri , Robinson Sarah , Moniz Caje

Parathyroid hormone is involved in calcium homeostasis through interactions with vitamin D. Because intact and truncated forms of parathyroid hormone (PTH) vary in their biological activity, assays that can accurately quantify the ratio of intact hormone to its fragments are of increasing significance in the diagnosis of endocrine, renal and bone diseases. Vitamin D and its metabolites circulate tightly bound to vitamin D-binding protein (DBP). Because DBP concentrations are a...

ea0086hdi1.4 | How do I...? 1 | SFEBES2022

How do I use TRAb measurements to guide management in my patient with Graves’ disease (GD)

Abraham Prakash

TSH receptor antibody (TRAb) assays are highly sensitive and specific for the diagnosis of GravesÂ’ disease. TRAb can minimise need for additional radiological modalities such as ultrasound and isotope scan in excluding other causes of hyperthyroidism. The relapse rates of hyperthyroidism following a course of anti- thyroid drugs (ATDs) remains disappointingly high at between 50-70%. TRAb levels at diagnosis and at the completion of a course of ATDs can be useful in predic...

ea0082wd12 | Workshop D: Disorders of the adrenal gland | SFEEU2022

A danger of treating hypothyroidism

Wood Kirsty , Abraham Prakash

This 46 year old lady with no significant past medical history was referred urgently to the Endocrine Investigation Unit with a 9 month history of increasing lethargy and gradual weight loss of around 5 kg. Two months prior, she had been diagnosed with subclinical hypothyroidism and after commencing Levothyroxine, quickly lost another 5 kg in weight over a period of 6 weeks and had postural dizziness with systolic BP readings between 80 and 90 mmHg. She was having a normal men...